Literature DB >> 12142396

Mammaglobin a: a promising marker for breast cancer.

Neil O'Brien1, Teresa M Maguire, Norma O'Donovan, Niamh Lynch, Arnold D K Hill, Enda McDermott, Niall O'Higgins, Michael J Duffy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12142396

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  10 in total

1.  Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer.

Authors:  Maria Kabisch; Justo Lorenzo Bermejo; Thomas Dünnebier; Shibo Ying; Kyriaki Michailidou; Manjeet K Bolla; Qin Wang; Joe Dennis; Mitul Shah; Barbara J Perkins; Kamila Czene; Hatef Darabi; Mikael Eriksson; Stig E Bojesen; Børge G Nordestgaard; Sune F Nielsen; Henrik Flyger; Diether Lambrechts; Patrick Neven; Stephanie Peeters; Caroline Weltens; Fergus J Couch; Janet E Olson; Xianshu Wang; Kristen Purrington; Jenny Chang-Claude; Anja Rudolph; Petra Seibold; Dieter Flesch-Janys; Julian Peto; Isabel dos-Santos-Silva; Nichola Johnson; Olivia Fletcher; Heli Nevanlinna; Taru A Muranen; Kristiina Aittomäki; Carl Blomqvist; Marjanka K Schmidt; Annegien Broeks; Sten Cornelissen; Frans B L Hogervorst; Jingmei Li; Judith S Brand; Keith Humphreys; Pascal Guénel; Thérèse Truong; Florence Menegaux; Marie Sanchez; Barbara Burwinkel; Frederik Marmé; Rongxi Yang; Peter Bugert; Anna González-Neira; Javier Benitez; M Pilar Zamora; Jose I Arias Perez; Angela Cox; Simon S Cross; Malcolm W R Reed; Irene L Andrulis; Julia A Knight; Gord Glendon; Sandrine Tchatchou; Elinor J Sawyer; Ian Tomlinson; Michael J Kerin; Nicola Miller; Christopher A Haiman; Fredrick Schumacher; Brian E Henderson; Loic Le Marchand; Annika Lindblom; Sara Margolin; Maartje J Hooning; Antoinette Hollestelle; Mieke Kriege; Linetta B Koppert; John L Hopper; Melissa C Southey; Helen Tsimiklis; Carmel Apicella; Seth Slettedahl; Amanda E Toland; Celine Vachon; Drakoulis Yannoukakos; Graham G Giles; Roger L Milne; Catriona McLean; Peter A Fasching; Matthias Ruebner; Arif B Ekici; Matthias W Beckmann; Hermann Brenner; Aida K Dieffenbach; Volker Arndt; Christa Stegmaier; Alan Ashworth; Nicholas Orr; Minouk J Schoemaker; Anthony Swerdlow; Montserrat García-Closas; Jonine Figueroa; Stephen J Chanock; Jolanta Lissowska; Mark S Goldberg; France Labrèche; Martine Dumont; Robert Winqvist; Katri Pylkäs; Arja Jukkola-Vuorinen; Mervi Grip; Hiltrud Brauch; Thomas Brüning; Yon-Dschun Ko; Paolo Radice; Paolo Peterlongo; Giulietta Scuvera; Stefano Fortuzzi; Natalia Bogdanova; Thilo Dörk; Arto Mannermaa; Vesa Kataja; Veli-Matti Kosma; Jaana M Hartikainen; Peter Devilee; Robert A E M Tollenaar; Caroline Seynaeve; Christi J Van Asperen; Anna Jakubowska; Jan Lubinski; Katarzyna Jaworska-Bieniek; Katarzyna Durda; Wei Zheng; Martha J Shrubsole; Qiuyin Cai; Diana Torres; Hoda Anton-Culver; Vessela Kristensen; François Bacot; Daniel C Tessier; Daniel Vincent; Craig Luccarini; Caroline Baynes; Shahana Ahmed; Mel Maranian; Jacques Simard; Georgia Chenevix-Trench; Per Hall; Paul D P Pharoah; Alison M Dunning; Douglas F Easton; Ute Hamann
Journal:  Carcinogenesis       Date:  2015-01-13       Impact factor: 4.944

2.  Mammaglobin-A immunohistochemistry in primary central nervous system neoplasms and intracranial metastatic breast carcinoma.

Authors:  Patrick J Cimino; Richard J Perrin
Journal:  Appl Immunohistochem Mol Morphol       Date:  2014-07

3.  Safety and preliminary evidence of biologic efficacy of a mammaglobin-a DNA vaccine in patients with stable metastatic breast cancer.

Authors:  Venkataswarup Tiriveedhi; Natalia Tucker; John Herndon; Lijin Li; Mark Sturmoski; Matthew Ellis; Cynthia Ma; Michael Naughton; A Craig Lockhart; Feng Gao; Timothy Fleming; Peter Goedegebuure; Thalachallour Mohanakumar; William E Gillanders
Journal:  Clin Cancer Res       Date:  2014-12-01       Impact factor: 12.531

4.  Mammaglobin, a valuable diagnostic marker for metastatic breast carcinoma.

Authors:  Zhiqiang Wang; Betsy Spaulding; Anna Sienko; Yiaoming Liang; Hongbao Li; Gitte Nielsen; Gyung Yub Gong; Jae Y Ro; Qihui Jim Zhai
Journal:  Int J Clin Exp Pathol       Date:  2008-12-01

5.  Expression analysis of mammaglobin A (SCGB2A2) and lipophilin B (SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their co-expression in gynecologic malignancies.

Authors:  Menelaos Zafrakas; Beate Petschke; Andreas Donner; Florian Fritzsche; Glen Kristiansen; Ruth Knüchel; Edgar Dahl
Journal:  BMC Cancer       Date:  2006-04-09       Impact factor: 4.430

6.  Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy.

Authors:  S Bellone; R Tassi; M Betti; D English; E Cocco; S Gasparrini; I Bortolomai; J D Black; P Todeschini; C Romani; A Ravaggi; E Bignotti; E Bandiera; L Zanotti; S Pecorelli; L Ardighieri; M Falchetti; C Donzelli; E R Siegel; M Azodi; D-A Silasi; E Ratner; P E Schwartz; T J Rutherford; A D Santin
Journal:  Br J Cancer       Date:  2013-06-27       Impact factor: 7.640

Review 7.  Human mammaglobin in breast cancer: a brief review of its clinical utility.

Authors:  Fawwaz Shakir Al Joudi
Journal:  Indian J Med Res       Date:  2014-05       Impact factor: 2.375

8.  Mammaglobin 1 mediates progression of trastuzumab-resistant breast cancer cells through regulation of cyclins and NF-κB.

Authors:  Ratih Kusumastuti; Yuji Kumagai; Seiichiro Ishihara; Atsushi Enomoto; Takashi Murakami; Motoaki Yasuda; Hisashi Haga
Journal:  FEBS Open Bio       Date:  2022-08-09       Impact factor: 2.792

9.  Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis.

Authors:  Eliana Bignotti; Renata A Tassi; Stefano Calza; Antonella Ravaggi; Elisa Rossi; Carla Donzelli; Paola Todeschini; Chiara Romani; Elisabetta Bandiera; Laura Zanotti; Mario Carnazza; Francesco Quadraro; Germana Tognon; Enrico Sartori; Sergio Pecorelli; Dana M Roque; Alessandro D Santin
Journal:  J Transl Med       Date:  2013-07-02       Impact factor: 5.531

10.  Measurement of serum PODXL concentration for detection of pancreatic cancer.

Authors:  Keisuke Taniuchi; Makiko Tsuboi; Masahiko Sakaguchi; Toshiji Saibara
Journal:  Onco Targets Ther       Date:  2018-03-15       Impact factor: 4.147
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.